articleTop 1% cited
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
Gastroenterology · 2006 · Vol. 132(1) · pp. 52–65
Jean–Frédéric Colombel✉(Centre Hospitalier Universitaire de Lille)William J. Sandborn(WinnMed)Paul Rutgeerts(KU Leuven)Robert Enns(St. Paul's Hospital)Stephen B. Hanauer(University of Chicago)Remo Panaccione(University of Calgary)Stefan Schreiber(Christian-Albrechts-Universität zu Kiel)Dan ByczkowskiJu Li(Abbott Fund)Jeffrey D. KentPaul F. Pollack
Inflammatory Bowel DiseaseAutoimmune and Inflammatory Disorders ResearchMicroscopic ColitisAdalimumabMedicinePlaceboInternal medicineCrohn's diseaseAdverse effectRandomized controlled trialGastroenterologyTumor necrosis factor alphaDisease
MeSH terms
AdalimumabAdolescentAdultAgedAntibodies, MonoclonalCrohn DiseaseFemaleHumansMaleMiddle AgedPlacebosRemission InductionSeverity of Illness IndexDigestive System FistulaTreatment Outcome
Citations
2,237
FWCI
57.99
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
Cited by
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Gut · 2012 · 1,472 citations
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
Gut · 2007 · 1,030 citations
Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula
Diseases of the Colon & Rectum · 2016 · 386 citations
ACG Clinical Guideline: Management of Crohn's Disease in Adults
The American Journal of Gastroenterology · 2018 · 1,376 citations
Review article: loss of response to anti-TNF treatments in Crohn’s disease
Alimentary Pharmacology & Therapeutics · 2011 · 612 citations
Guidelines for the management of inflammatory bowel disease in adults
Gut · 2011 · 1,432 citations
Management of Crohn's Disease in Adults
The American Journal of Gastroenterology · 2009 · 1,184 citations
Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
Clinical Pharmacology & Therapeutics · 2012 · 502 citations
References
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
Arthritis & Rheumatism · 2003 · 1,756 citations
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
Arthritis & Rheumatism · 2004 · 1,168 citations
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial
Arthritis & Rheumatism · 2005 · 902 citations
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
Gastroenterology · 2006 · 1,710 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.